Up 1.6% to $24.15, Alnylam Pharmaceuticals (NASDAQ:ALNY), is one of today's notable movers. The S&P is trading fractionally higher to 1,565 and the Dow is trading 0.2% higher to 14,561.
In the past 52 weeks, Alnylam Pharmaceuticals share prices have been bracketed by a low of $9.51 and a high of $25.80 and are now at $24.15, 154% above that low price. The 200-day and 50-day moving averages have moved 1.02% higher and 0.82% higher over the past week, respectively.
Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.
There is potential upside of 22.2% for shares of Alnylam Pharmaceuticals based on a current price of $24.15 and an average consensus analyst price target of $29.50. The stock should find initial support at its 50-day moving average (MA) of $23.98 and further support at its 200-day MA of $18.78.